Market Insights: Nudging higher

While the broader market is modestly higher, lower-than-forecast earnings from Resmed and a profit warning from AMP has seen both stocks hammered in morning trade.

No carousel of other videos after the video ends.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles